Abstract The mammalian retina contains multiple neurons, each of which contributes differentially to visual processing. Of these retinal neurons, amacrine cells have recently come to prime light since they facilitate majority of visual processing that takes place in the retina. Amacrine cells are also the most diverse group of neurons in the retina, classified majorly based on the neurotransmitter type they express and morphology of their dendritic arbors. Currently, little is known about the molecular basis contributing to this diversity during development. Amacrine cells also contribute to most of the synapses in the inner plexiform layer and mediate visual information input from bipolar cells onto retinal ganglion cells. In this review, we will describe the current understanding of amacrine cell and cell subtype development. Furthermore, we will address the molecular basis of retinal lamination at the inner plexiform layer. Overall, our review will provide a developmental perspective of amacrine cell subtype classification and their dendritic stratification.
Introduction
The neural retina is broadly categorized into seven distinct cell types ( The diversity of retinal neurons goes further beyond retinal cell classification with each retinal cell type being further classified into many subtypes [3] . This neuronal diversity is brought about during retinogenesis by the changing competence of progenitor cells with time [4] . This leads to the specification and differentiation of different retinal cell classes and their subtypes and a distinction in their laminar stratification.
Recently, amacrine cells and their multitude of subtypes have been of particular interest, partly because amacrine cells display the highest degree of diversity in both morphology and function in the retina [5, 6 • ]. So far, up to thirty distinct subpopulations of amacrine cells have been identified based on the neurotransmitter type they express, dendrite morphology, and/or functional characteristics [3, 5] . However, the list is still growing and the precise number of subtypes of amacrine cells is currently unknown.
Subtype Classification of Amacrine Cells
Amacrine cells have been categorized into at least 33 different subtypes based on their dendritic morphology and stratification. Pioneering studies by Masland, Vaney, Wassle, and others identified these subtypes of amacrine cells in the rodent retina [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Based on how proliferative their dendritic arbors are, they are categorized as narrow-field amacrine cells (dendritic arbor of around 70 lm in diameter), medium-field amacrine cells (dendritic arbor of around 170 lm in diameter), and wide-field amacrine cells (dendritic arbor of about 350 lm in diameter). Amacrine cells contribute toward majority of synapses in the IPL. Based on axonal projections of OFF and ON bipolar cells, the IPL is divided into an OFF lamina and an ON lamina, respectively. These laminas are further divided into five parallel sublaminas (S1-S5) based on the dendritic stratification of subtypes of amacrine cells [1, 2 • ] (Fig. 1b) .
Based on their ramification in the IPL, amacrine cells are classified into various subtypes. The details of individual subtypes categorized based on morphology will not be discussed here, an extensive review being available in
Amacrine cells are inhibitory interneurons that project their dendritic arborization to the IPL where they intercept retinal ganglion cells and/or bipolar cells. Based on the inhibitory neurotransmitter type they express, amacrine cells are classified into two major subpopulations: GABAergic and glycinergic types [6, 10] . A small population of amacrine cells has also been found to be neither GABAergic nor glycinergic [16 • ]. GABAergic amacrine cells are distributed in both the GCL as well as the INL, have mostly wide-field dendritic arbors, and can be further classified by their expression of neurotransmitters and neuropeptides such as choline acetyl transferase (ChAT), neuropeptide Y (NPY), tyrosine hydroxylase (TH), or nitric oxide synthase (NOS) [12 • , 17-21] . Glycinergic amacrine cells are largely restricted to the INL, have mostly narrowfield dendritic arbors, and can be further identified by the expression of Disabled-1 (Dab1), parvalbumin (PV), or vesicular glutamate transporter type 3 (VGlut3) [12 • , 13, 14, 22-25] . Developmentally, GABAergic amacrine cells are born first with their developmental peak at about E14, while glycinergic amacrine cells are born later with peak of birth at about P0 [26] .
Neurotransmitters and neuropeptide markers are useful in distinguishing between the different cell subtypes of amacrine cells. Calcium binding proteins such as calbindin and calretinin have also been used to characterize amacrine cells and specifically to visualize their stratification in the IPL. Depending on the species, calretinin, for instance, marks a subclass of amacrine cells and retinal ganglion cells. It also labels three prominent strata of the IPL-S2, S3, and S4, with weak expression also seen in S1 (Fig. 1b) . Calbindin marks horizontal cells, some amacrine cells and . Developmentally, cholinergic amacrine cells are among the first to be specified at around E11 [26 • ]. Cholinergic amacrine cells in the GCL are born first followed closely by cholinergic amacrine cells of the INL, lending credence to a theory that the position of soma in the retina might correlate with birthdates. Starburst amacrine cells are among the most extensively studied subset of amacrine cells, and it is well known that starburst amacrine cells play a major role in modulating the response of direction sensitive retinal ganglion cells and hence contribute to direction selectivity and detection of directional motion (reviewed in [27] ).
NPY is expressed in a population of GABAergic amacrine cells that are located in both the INL and GCL. NPY cells in the INL project their dendrites mostly to the OFF sublamina S1, while those in the INL, to the ON sublamina S5 [18, 20] . A small population of NPY cells also expresses TH and projects to S3 sublamina. Interestingly, Voinescu et al. [26 • ] found coincidental expression of NPY in all cholinergic amacrine cells at P7. As development proceeds, NPY expression in cholinergic amacrine cells reduces. This indicates that not only do progenitor cells change their competence to produce different retinal types, but the same mechanism might be at play in specifying retinal cell subtypes as well. Functionally, NPY seems to have a role in mediating low-frequency spatial processing (large spatial patterns) by retinal ganglion cells [28] .
Almost all dopaminergic amacrine cells (TH expressing) are GABAergic and are located at the boundary of INL and IPL and ramify in S1 lamina of the IPL. Studies that use a TH promoter-driven RFP/GFP line identify a group of GABAergic catecholaminergic cells (Type II cells) that do not contain dopamine and specifically stratify in S3 [21, 29] . It is possible these cells express NPY as reported by Oh et al. [18] who found a subpopulation of NPY cells that were immunoreactive for TH. Functionally, dopaminergic amacrine cells modulate light adaptation and circadian rhythm.
Another group of GABAergic amacrine cells express neuronal NOS. NOS-expressing amacrine cells have been categorized further based on the size of their soma and dendritic arborization. Types I and II are situated in the INL and ramify in S1 and mainly in S3. The displaced NOS amacrine cells in the GCL ramify mainly in S4 and S5 [17, 30] . NOS amacrine cells usually intercept and interact with other amacrine cells in the IPL, but some synapse with retinal ganglion cells as well. Some cells also mediate input from bipolar cells projecting to the ON sublamina. Current studies seem to suggest that NO amacrine cells might play a role in visual adaptation since NO synthesis is largely dependent on stimulation by light [19, 30] .
Glycinergic amacrine cells are not extensively characterized due to the lack of an extensive marker set to label the different subtypes of glycinergic cells. Glycinergic amacrine cells as a whole are marked by glycine transporter (GlyT1) [14] . One well-characterized subset of glycinergic amacrine cells is the AII amacrine cells [9, 24, 31] . AII amacrine cells are present primarily in the INL and are rarely found in the GCL. They can be marked by cytoplasmic protein DAB1, which is part of the reelin pathway that controls cell positioning during development in parts of the central nervous system. DAB1 is visibly expressed in AII glycinergic amacrine cells as early as P7 in the mouse retina [22] . PV is another marker for AII amacrine cells as PV-expressing cells are morphologically similar to AII amacrine cells and also co-express DAB1 [12, 22, 23] . In the adult mouse retina, the AII amacrine cells ramify primarily in the ON S5 sublamina. DAB1 immunoreactivity is also discernible as thick lobules at the distal part of the OFF sublamina. Studies have suggested that these lobules are sites of inhibitory interaction between AII amacrine cells, OFF bipolar cells, and OFF retinal ganglion cells. The inhibitory interaction between AII amacrine cells and OFF bipolar cells may be important for visual responses at high spatial frequencies and/or detecting motion of varying spatiotemporal contrasts [31] .
Vesicular glutamate transporter type 3 (VGlut3) is expressed in a subset of glycinergic amacrine cells in the INL. VGlut3 amacrine cells ramify in the ON and OFF sublaminas (S2 and S3), filling in the gaps between the three calretinin bands and seem to make connections with OFF cone bipolar cells at S2, ON cone bipolar cells at S3, and rod bipolar cells at S4/S5 [13, 32] . VGlut3 cells seem to receive inputs primarily from amacrine cells and hence are thought to be involved in amacrine-to-amacrine cell crossover inhibition. A population of VGlut3 cells expresses circadian clock gene Period 1 (Per1) suggesting that this population might have a role in generating circadian rhythms [25] .
There is also a small population of amacrine cells that are neither GABAergic nor glycinergic (nGnG). Roughly 85 % of amacrine cells are accounted for, by staining with glutamic acid decarboxylase 65/67 (GAD65/67) for GABAergic cells or GlyT1 for glycinergic amacrine cells. The remaining *15 % of amacrine cells express neither. The neurotransmitter type(s) expressed by these amacrine cells is currently unknown. nGnG amacrine cells ramify primarily to the OFF lamina (S1-S3) of the IPL with their dendritic arborization being morphologically narrow field.
Developmentally, these cells are born after glycinergic cells during the first few postnatal days [16 • ].
Amacrine Cells Contribute to the Majority of Synapses Formed in the IPL
Amacrine cells and bipolar cells project presynaptic dendrites to the IPL where they synapse with retinal ganglion cells. Various aspects of visual information encoded by retinal neurons are transmitted to retinal ganglion cells via specific synapses in the IPL, and hence it is pertinent that the specification of IPL occurs in a well-directed and timely manner. Yamagata et al. [33] first identified and elucidated the role of two homologous transmembrane immunoglobulin superfamily molecules (sidekick family)-Sdk1 and Sdk2-in retinal lamination of the chick retina. They found that Sdk1 and Sdk2 are expressed in mutually exclusive populations of retinal neurons in the INL and GCL. While Sdk2 expression is greater in sublamina S2 of the IPL and weaker in S4, the opposite is true of Sdk1. Over-expression of Sdks in cells that are devoid of it, rerouted these cells to the Sdk-positive layer without a change in cell identity. This suggests that Sdks play an important role in promoting laminar synaptic formation by promoting synapse formation between pre-and post-synaptic Sdk-positive neurons. Further, they have identified the presence of related adhesion molecules, Dscam and DscamL, in exclusive layers of the IPL. Dscam expression is restricted to S5, while DscamL is expressed in S1, S2, and S4 [34] . Dscam is also localized to the somata of the TH-and NOS-expressing amacrine cells. Loss-and gainof-function studies demonstrated that the Dscam adhesion molecules along with Sdks regulate the development of sublaminar stratification across the IPL [34] . Dscams are also shown to influence mosaic spacing by promoting selfavoidance between different types of amacrine cells in the INL, which is essential to preserve functionality of amacrine neurons [35] . Another class of transmembrane signaling molecules-semaphorins, signaling via their receptors-plexins, display complementary expression patterns across the IPL and regulate retinal lamination during development [36, 37] . In Sema5A and Sema5B double null mutants, TH-and VGlut3-expressing amacrine cells display gross dendritic mistargeting in the IPL. Other amacrine types like AII amacrine cells, cholinergic amacrine cells, calretinin, and calbindin-expressing amacrine cells display prominent ectopic projections of dendrites toward the OPL. Double null mutants of receptors PlexA1 and PlexA3 phenocopy the anomalies in stratification displayed by Sema5A and Sema5B double mutants [37] . Sema6A ligand and PlexA4 receptor combination are also expressed in a complimentary manner through IPL development. PlexA4 is expressed in S1 and S2, and Sema6A is expressed in S3, S4, and S5 laminas of the IPL. PlexA4 mutants display aberrant dendritic projections of THexpressing amacrine cells, calbindin-expressing amacrine cells, and intrinsically photosensitive retinal ganglion cells, with Sema6A-null mutants phenocopying the aberrant dendritic stratification, suggesting that Sema6A acts a functional ligand for PlexA4 in regulating retinal lamination at the IPL [36] . Taken together, transmembrane guidance molecules have been shown to regulate neurite stratification and retinal lamination at the IPL by influencing the development of dendritic arborization of amacrine cells among others. Recent studies in Zebrafish have shown the role of transcription factor Irx7 in regulating retinal lamination by affecting neurite outgrowth [38] . Another factor namely PTEN phosphatase also mediates the mosaic spacing, fasciculation, and dendritic arborization of TH amacrine cells and of horizontal cells, likely in a Dscam/Sema-independent manner [39] . Although we currently understand the role of these signaling molecules in IPL development, we are yet to assimilate the full network of molecules upstream and downstream of the signaling factors that play into this regulation.
Transcription Factors Influencing the Development of Amacrine Cell Types and Subtypes
During development, amacrine cells are specified early along with retinal ganglion cells, cone photoreceptors, and horizontal cells. Bipolar cells, rod photoreceptors, and Müller glial cells are specified later. In mouse retina, amacrine cells are born between embryonic day 8 (E8) and postnatal day 5 (P5), with the peak of competence between E14 and E16 [4, 26] . The competence of the early retinal progenitor pool changes with time and the expression of intrinsic factors such as transcription factors are instrumental in specifying the identity of the retinal cell class as a whole and of individual cell subtypes. Here, we discuss some of the molecular factors governing the differentiation and specification of amacrine cells and their subtypes.
Early factors such as Pax6, Sox2, Bclaf1 influence the competence of retinal progenitors and significantly impact the development of amacrine cells from the early progenitor pool. Initial studies on Pax6 showed that a conditional deletion of Pax6 in the eye resulted in the production of only amacrine cells with a loss of most other neuron types and is hence necessary for the maintenance of progenitors in their multi-potent state [40, 41] . Furthermore, all amacrine cells born in the Pax6 mutant were identified as GABAergic, hence further restricting the progenitor fate choice to a non-glycineric amacrine cell type. Bclaf1 has been recently identified as a factor that could potentially act along with Pax6 in the differentiation of early retinal neuron population [42] . Sox2 is expressed in Müller glial cells and the cholinergic subset of amacrine cells in the adult retina. During development, over-expression of Sox2 in explant cultures biases progenitor cells to an amacrine cell fate [43] .
Conditional deletion and over-expression studies of Foxn4 show that it is necessary and sufficient for the generation of amacrine and horizontal cells. Foxn4 deletion greatly attenuated amacrine cell numbers, while an overexpression of Foxn4 in progenitors greatly facilitated amacrine cell fate (both glycinergic and GABAergic) at the expense of rod photoreceptors [44, 45 • ] . Recent studies in the chick retina have shown that Foxn4 expression might be in part regulated by Meis1, which regulates the activity of a non-coding DNA fragment upstream of the Foxn4 transcription start site [46] . Foxn4 also interacts with its downstream targets-Neurod4 (previously Math3) and Neurod1, and regulates the differentiation of multi-potent progenitors into amacrine cells [44] . A loss of Neurod4 or Neurod1 alone does not affect amacrine cell numbers, whereas a double mutant of Neurod1 and Neurod4 completely abolished amacrine cell generation. An overexpression of Neurod4 or Neurod1 alone does not restore amacrine cell numbers, but addition of Pax6 to either Neurod1 or Neurod4 is sufficient to generate amacrine cells [47] . This signifies that Neurod4 and Neurod1 have mutually redundant functions in amacrine cell genesis, and act downstream of Foxn4 and Pax6. While they are together essential for the generation of amacrine cells, they are not sufficient for amacrine cell genesis. Another factor acting downstream of Foxn4 is Ptf1a, the loss of which biases precursors of amacrine and horizontal cells into retinal ganglion cell fate leading to greatly reduced amacrine cell numbers [48, 49] . Gain-of-function and loss-offunction studies in the Xenopus retina indicate that Ptf1a might be particularly essential for the development of GABAergic fate in amacrine cells [50] .
Several transcription factors have been studied for their role in amacrine subtype specification. Barhl2 is one such factor, which is expressed in bipolar cells, amacrine cells, and retinal ganglion cells. A forced expression study of Barhl2 suggested that it might be an important regulator of the glycinergic subtype development [51] . Loss-of-function studies have shown that Barhl2 attenuates both glycinergic and GABAergic amacrine cell numbers with a concomitant increase in cholinergic amacrine cells [52] . Isl1 has been extensively studied for its role in cholinergic amacrine cell development. Isl1 is expressed in retinal ganglion cells, cholinergic amacrine cells, and bipolar cell subtypes [53] . Loss of Isl1 results in the loss of about 93 % of cholinergic amacrine cells and a concomitant disruption of the S2 and S4 stratification in the IPL [54] . Bhlhb5 is expressed in GABAergic amacrine cells and cone bipolar cells in the adult. Loss of Bhlhb5 expression results in a loss of about a third of GABAergic cells. TH cells seem to be the most affected one with about a 90 % decrease in Bhlhb5 mutants [55] . Lineage tracing studies have shown that Bhlhb5-expressing progenitors give rise to cholinergic, glycinergic, and GABAergic amacrine cell fates. The expression in the adult in cholinergic and glycinergic amacrine cells is downregulated but is retained in GABAergic amacrine cell subtypes [56] . Lmo4 is expressed in a subset of GABAergic amacrine cells, and a conditional deletion of Lmo4 leads to a reduction in the number of Bhlhb5-expressing GABAergic amacrine cells [57] . Analysis of specific expression of individual members of the Neurod1 transcription factor family showed the expression of Neurod2 specifically in Dab1-expressing AII amacrine cells. Loss of Neurod2 results in a partial loss of AII amacrine cells [58] . Neurod6 expression in adult amacrine neurons was also identified and is expressed mostly in nGnG amacrine cells [16, 58] . Loss of Neurod6 results in an increase in the number of glycinergic amacrine cells at the expense of nGnG amacrine cells [16 • ]. Interplay between Neurod6 and Satb2/Ebf3-expressing amacrine cells regulates the decision of the progenitor cells to differentiate into glycinergic amacrine cells versus the nGnG fate. Ebf class transcription factors have been studied for their role in the differentiation of AII class amacrine cells. Gain-and loss-of-function studies indicate that Ebf class transcription factors are both necessary and sufficient for specifying AII amacrine subtypes [59] .
What Remains Unknown?
We are currently aware of the presence of the many subtypes of amacrine cells but unclear on their individual functions in processing visual information. We have elucidated some of the transcription factors that play an important role in the development of amacrine cells class as a whole, but our understanding of how these factors come together or compete with other factors responsible for specifying other retinal cell types is currently limited. Molecular mechanisms governing the development of individual amacrine cells subtypes and their specific laminar stratification are also currently limited. Identifying unique regulatory factor or a unique combination of factors responsible for amacrine subtype specification will be useful for answering some of these questions. We are now beginning to understand the molecular basis of laminar stratification and mosaic tiling of amacrine cells, but are yet to determine the influence of the complete synaptic laminar network involving retinal ganglion cells, amacrine cells, and bipolar cells on retinal function. Identifying the developmental factors responsible for laminar stratification has been immensely useful, allowing us to mark cells and their synaptic contributions to the IPL. More work in this direction will help put together a developmental framework which will ultimately provide us with a deeper understanding of amacrine cells and their contribution to visual information processing.
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